Skip to main content

Table 7 Inhibitory effect of OVMS against S. aureus

From: DoE approach for development of localized controlled release microspheres of Vancomycin for treatment of septic arthritis

Formulation Zone of inhibition (cm)
Marketed formulation (IV powder) 1.9 ± 0.1
Test formulation (VMS) 1.5 ± 0.1
  1. Data are represented as mean ± SD (n = 3)